Media

KAREN AIACH SE LANCE DANS LA RECHERCHE POUR SAUVER SA FILLE MALADE

Handicap.fr - 28 septembre 2017 

KAREN AIACH, CEO DE LYSOGENE, REMPORTE LE PRIX DE LA FEMME ENTREPRENEUR DE L'USINE NOUVELLE

LYSOGENE PRESENTERA SES AVANCEES LORS DU SYMPOSIUM MPS 2017 DE L'ORPHAN DISEASE CENTER

Capital.fr - 10 July 2017

LYSOGENE AVANCE A PLEINE VAPEUR

Biotech Info - 22 June 2017

LYSOGENE LUTTE CONTRE LES MALADIES RARES NEURODEGENERATIVES DE L'ENFANT 

La Jaune & la Rouge - 19 June 2017

10 ENTREPRENEUSES DE LA FRENCH TECH

Les Echos Business - 19 June 2017

LES 15 HEROINES DE LA FRENCH TECH

Les Echos - 16 June 2017

KAREN AIACH FEATURED ON THE GROWTH SHOW

New York - 13 June 2017

KAREN AIACH PRESENTS AT THE ROYAL SOCIETY OF MEDECINE

London - 22 April 2017

KAREN AIACH LIVE ON CHEDDAR AT THE NYSE

Cheddar - 12 September 2016

KAREN AIACH, UNE MERE COURAGE DEVENUE ENTREPRENEURE DANS LES MALADIES RARES 

AFP - 9 September 2016

SUPERHUMAN 

The Promise of Gene Therapy - 15 August 2016 

KAREN AIACH KEYNOTE SPEECH AT HARVARD PRECISION MEDICINE CONFERENCE 2016 

Rare Informs the Common - 15 July 2016

MOM-ENTREPRENEUR FORMS GENE THERAPY COMPANY TO TACKLE SANFILIPPO SYNDROME 

Vector - 5 July 2016

Q & A WITH RARE DISEASE MOM AND BIOTECH CEO KAREN AIACH 

Boston Business Journal - 23 June 2016

ALL IN  THE FAMILY 

Scientific American World View - 21 June 2016

LYSOGENE IS ONE OF 15 AWESOME BIOTECHS TO KNOW IN PARIS 

Labiotech.eu - 5 April 2016

RESEARCHING GENE THERAPIES FOR RARE DISEASES  KAREN AIACH INTERVIEWED BY INNOVATOR'S CORNER 

PharmaVoice - 1 February 2016

PARENTS OF CHILDREN WITH RARE DISEASES FIND HOPE IN FOR-PROFIT COMPANIES 

New York Times - 25 December 2015

KAREN AIACH INTERVIEW WITH CHALLENGES MAGAZINE

Challenges - 3 December 2015

KAREN AIACH INTERVIEW WITH LABIOTECH.EU

Labiotech.eu - 27 October 2015

KAREN AIACH AND LYSOGENE FEATURE IN A NATASHA LODER ARTICLE ON GENOME EDITING

The Economist - August 21, 2015

KAREN AIACH INTERVIEW WITH FORBES

Forbes - July 27, 2015

LYSOGENE CEO SAYS GENE THERAPY COMPANY IN PRE-IPO FUNDING TALKS

Bloomberg - July 27, 2015

BIG BANG PURE TECH

BIGBpifranceInnoGeneration - June 10, 2015 

MOM LAUNCHES COMPANY TO CURE DAUGHTER'S FATAL DISORDER

Yahoo! Finance - May 2015

NATURE BIOTECHNOLOGY’S TOP ELEVEN BIOTECHS 2014

Nature Biotechnology - March 2015

INDUSTRY-ACADEMIA ATTACK ON GM1-GANGLIOSIDOSIS

DDNEWS - March 2015

KAREN AIACH, UNE MERE A L'ASSAUT DES MALADIES RARES DU CERVEAU

Les Echos - February 4, 2015

MALADIES RARES: LE COMBAT DE KAREN AIACH

12/14 LCI - July 17, 2014

KAREN AIACH, L'ACHARNÉE

Le Figaro - July 10, 2014

LYSOGENE :  LE PREMIER PRODUIT PÉDIATRIQUE EUROPÉEN EN THÉRAPIE GÉNIQUE ENTRE EN PHASE I/II

Biotechs Actualités Pharma- n° 15 December 2011 

LA BIOTECH LYSOGENE S'ATTAQUE A UNE MALADIE RARE

Le Figaro - September 12, 2011

LYSOGENE LAUCHES THE FIRST GENE THERAPY CLINICAL TRIAL IN SANFILIPPO DISEASE

News-Medical.net - August 16, 2011

MALADIE DE SANFILIPPO : L'ESPOIR DE LA THÉRAPIE GÉNIQUE

Doctissimo - May 10, 2011

LYSOGENE SOUTIENT UN ESSAI

Les Echos - April 28, 2011 

MALADIES RARES : LYSOGENE SE LANCE DANS LA THÉRAPIE GÉNIQUE

La Tribune - April 26, 2011